Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons

Acta Anaesthesiol Scand. 1996 Feb;40(2):244-9. doi: 10.1111/j.1399-6576.1996.tb04427.x.

Abstract

Background: Sepsis and septic shock lead to activation of the complement cascade and to the release of pro-inflammatory cytokines.

Methods: The effects of E coli infusion and of infusion of anti-TNF antibodies and a xanthine derivative (HWA 138) on complement activation and cytokine release was evaluated in 17 baboons. All animals received 5 x 10(8) live bacteria per kg body weight. Five animals received only bacteria, five received in addition 0.5 mg per kg body weight of anti-TNF-antibody, and seven received an infusion of 6 mg per kg body weight of HWA 138 in addition to the bacteria.

Results: In baboons receiving 5 x 10(8) live E coli per kg body weight increased plasma levels of TCC, TNF-alpha and IL-8 were found. The release of TNF-alpha was lower in the group receiving HWA 138 at 2 h after the infusion. In baboons receiving an infusion of anti-TNF antibody the concentration of IL-8 was lower at 2 and 4 h than in animals receiving just E coli or HWA 138.

Conclusion: Infusion of anti-TNF-antibody before E coli infusion will decrease the formation of IL-8. Infusion of HWA 138 before the E coli infusion will also inhibit the formation of TNF-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / administration & dosage*
  • Complement Activation*
  • Complement Membrane Attack Complex / metabolism
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / physiopathology
  • Hemodynamics
  • Interleukin-8 / biosynthesis*
  • Male
  • Papio
  • Pentoxifylline / analogs & derivatives*
  • Pentoxifylline / pharmacology
  • Sepsis / immunology*
  • Sepsis / physiopathology
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / immunology
  • Xanthines / pharmacology

Substances

  • Antibodies
  • Complement Membrane Attack Complex
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • Xanthines
  • 1-(5-hydroxy-5-methylhexyl)-3-methylxanthine
  • Pentoxifylline